Status:
COMPLETED
Drug Use Investigation for HEPSERA (Adefovir) Tablet
Lead Sponsor:
GlaxoSmithKline
Conditions:
Hepatitis B
Eligibility:
All Genders
Brief Summary
This post-marketing surveillance (PMS) is conducted to collect safety and efficacy data among subjects with chronic hepatitis B and hepatic cirrhosis B who is treated with adefovir tablets.
Eligibility Criteria
Inclusion
- Subjects with chronic hepatitis B or hepatic cirrhosis B
- Subjects treated with adefovir tablets
Exclusion
- None
Key Trial Info
Start Date :
February 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
436 Patients enrolled
Trial Details
Trial ID
NCT01863589
Start Date
February 1 2005
End Date
July 1 2012
Last Update
May 29 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.